Surgical treatment of pancreatic cancer-What is new?

Chirurg. 2022 Mar 31. doi: 10.1007/s00104-022-01618-7. Online ahead of print.ABSTRACTThe incidence of pancreatic ductal adenocarcinoma is continuously increasing and will become the second leading cause of cancer-related death in Europe and the USA by 2030. With a 5-year overall survival rate of less than 10% the prognosis remains poor. So far surgical tumor resection remains the only curative treatment option, which is now partially supported by multimodal neoadjuvant and adjuvant therapy concepts. Due to the aggressive tumor biology patients with advanced pancreatic cancer in particular can profit from these multimodal therapy concepts. Additionally, in recent years surgical treatment was optimized, the criteria for tumor resectablity were defined and minimally invasive surgery was widely introduced. This review article summarizes the newest developments and the new German S3 guidelines concerning surgery of pancreatic cancer.PMID:35357553 | DOI:10.1007/s00104-022-01618-7
Source: Der Chirurg - Category: Surgery Authors: Source Type: research